Publications and Posters

How can MSI enhance our understanding of ASO distribution?
January 1, 2025  •  van der Vloet, L., Hilaire, P. B. S., Bouillod, C., Isin, E. M., Heeren, R. M. A., & Vandenbosch, M. (2025).   In Drug Discovery Today ...
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease
September 18, 2024  •  Minnella, A., McCusker, K. P., Amagata, A., Trias, B., Weetall, M., Latham, J. C., O’Neill, S., Wyse, R. K., Klein, M. B., & Trimmer, J. K. (2024). In H. Nakano (Ed.), PLOS ONE (Vol. 19, Issue 9, p. e0309893). Public Library of Science (PLoS). • Drug study incorporating MALDI-IHC, Pharma
Multiplex and multiomic MS imaging of drugs, metabolites, and immunolabeled pathogenic protein markers within a single tissue section
June 2, 2024  •  ASMS 2024 • Prem Shankar; Reina N Paez; David Beaver; Bandana Bera; Brendan Prideaux
Combining Drug and Targeted Protein Imaging to Uncover Molecular Changes Associated with Cancer Treatment
June 2, 2024  •  ASMS 2024 • Erin H. Seeley, Catherine A. Kita, Gargey Yagnik, Kenneth J. Rothschild, Mark J. Lim, Rahul A. Sheth